Bottom line
JIRE vs IEFA: the short answer
JIRE (JPMorgan International Research Enhanced Equity ETF) and IEFA (iShares Core MSCI EAFE ETF) share a meaningful slice of their top holdings — about 62% by weight.
But IEFA is far broader, holding 2,632 positions to 214 for JIRE, so beyond the top names it adds exposure JIRE doesn't have.
IEFA is cheaper at 0.07% vs 0.24% — a difference of $17 a year per $10,000 invested.
Over five years, JIRE returned +9.7% a year vs +4.5% for IEFA (reporting dates differ).
Updated Nov 19, 2026
JIRE vs IEFA side by side
| JIRE | IEFA | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | J.P. Morgan | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.24% | 0.07% |
| Annual cost per $10k | $24 | $7 |
| 10-yr cost on $10k (prospectus) | $363 | $90 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +32.1% | +3.4% |
| 5-yr return (annualized) | +9.7% | +4.5% |
| 10-yr return (annualized) | +8.2% | +5.4% |
| Best quarter | +17.8% | +18.0% |
| Worst quarter | −23.4% | −23.5% |
| Net assets (fund) | $11.2B | $190.1B |
| Number of holdings | 214 | 2,632 |
| Portfolio turnover | 25% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JIRE | IEFA | Difference |
|---|---|---|---|
| 2024 | +3.0% | +3.4% | −0.4% |
| 2023 | +19.7% | +17.6% | +2.0% |
| 2022 | −13.7% | −15.1% | +1.4% |
| 2021 | +12.9% | +11.3% | +1.6% |
| 2020 | +5.4% | +8.6% | −3.1% |
| 2019 | +22.0% | +22.7% | −0.7% |
| 2018 | −14.7% | −14.2% | −0.5% |
| 2017 | +23.3% | +26.4% | −3.2% |
| 2016 | +2.1% | +1.4% | +0.7% |
Source: Fund prospectus bar charts
Holdings overlap
11 of JIRE's top 25 holdings also appear in IEFA's top 25.
| Holding | JIRE | IEFA |
|---|---|---|
| ASML Holding NV | 3.48% | 2.50% |
| AstraZeneca plc | 1.69% | 1.00% |
| Shell plc | 1.55% | 1.00% |
| HSBC Holdings plc | 1.54% | 1.42% |
| Allianz SE | 1.51% | 0.74% |
| Banco Santander SA | 1.36% | 0.79% |
| Nestle SA | 1.33% | 1.00% |
| Roche Holding AG | 1.32% | 1.20% |
| Sumitomo Mitsui Financial Group, Inc. | 1.22% | 0.61% |
| Novartis AG | 1.22% | 1.12% |
| UBS Group AG | 0.97% | 0.65% |
Source: SEC Form N-PORT
JIRE top 10
- ASML Holding NV — 3.48%
- Siemens AG — 1.78%
- AstraZeneca plc — 1.69%
- Shell plc — 1.55%
- HSBC Holdings plc — 1.54%
- Allianz SE — 1.51%
- Banco Santander SA — 1.36%
- UniCredit SpA — 1.33%
- Nestle SA — 1.33%
- Roche Holding AG — 1.32%
IEFA top 10
- ASML Holding N.V. — 2.50%
- Hsbc Holdings Plc — 1.42%
- Roche Holding AG — 1.20%
- Novartis AG — 1.12%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
- Nestle S.A. — 1.00%
- Astrazeneca Plc — 1.00%
- Shell Plc — 1.00%
- Siemens Aktiengesellschaft — 0.95%
- Mitsubishi UFJ Financial Group, Inc. — 0.93%
FAQ
What is the difference between JIRE and IEFA?
Which is cheaper, JIRE or IEFA?
Should I own both JIRE and IEFA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.